Spark Biomedical Partners With AcuityMD To Quickly Build New Market of Non-Invasive Therapeutics For Opioid Addiction

Spark Biomedical, a leading developer of wearable neurostimulation solutions, has partnered with AcuityMD, a commercial platform for medical technology companies, to accelerate Spark Biomedical’s expansion of a new and growing market for treatment of withdrawal associated with opioid addiction. Spark Biomedical’s U.S. Food & Drug Association (FDA)-approved Sparrow Therapy System is a drug-free tool that includes a consumer controller and earpiece that send mild electrical impulses to the brain to help alleviate opiate withdrawal symptoms.

Spark Biomedical’s novel therapeutic aids detoxification with 84% of participants experiencing mild to no withdrawal symptoms within 60 minutes . . .